معرفی
Lu Qiao is a Researcher in the Department of Surgery at Yale University's School of Medicine. Their work focuses on immunology, cancer biology, and virology, with a particular emphasis on mechanisms of immune evasion in cancer and viral infections such as SARS-CoV-2. Research interests include MHC-I pathways, antigen presentation, and drug design for therapeutic interventions.
Key areas of expertise involve structural biology of immune receptors (e.g., LAG-3), molecular mechanisms of tumor immune suppression, and mechanistic studies of viral entry processes. Lu Qiao has contributed to studies on Siglec-15 as a cancer immunotherapy target and the role of myeloid cells in SARS-CoV-2 pathogenesis.
Recent research highlights include investigations into gasdermin D's role in maintaining intestinal immune tolerance and the development of novel probes for studying protein entry into cells. Their work bridges fundamental molecular biology with translational applications in drug discovery and antiviral therapies.
